@SanofiUK Twitter Account Terms of Use

You will find hereafter the Terms of Use governing your Interaction with @SanofiUK (hereinafter and referred to on the @SanofiUK biography as "Terms"). These Terms supplement Twitter terms in respect of Interactions, being specified that Interactions must also comply with Twitter terms. By Interacting with @SanofiUK you (hereinafter "You") are deemed agreeing to comply with these Terms.

@SanofiUK is operated by Aventis Pharma Limited. One Onslow Street Guilford, Surrey, GU1 4YS (company registration number 01536540), with a view to Sanofi's Corporate and Institutional information in the UK. If you are not covered by the geographical audience, please do not interact with @SanofiUK.

This version of the Terms is dated May 2014 and governs the Interaction with @SanofiUK as from July 2016. The Terms may be subject to revisions from time to time. Such revisions will be announced via a Tweet and You will have the possibility of deciding whether You want to continue to Interact with @SanofiUK under the revised Terms. Any use of @SanofiUK subsequent to the entry into force of any revised version of the Terms of @SanofiUK is deemed an acceptance of and an agreement to abide by such revised version of Terms.

1. Definitions:

All capitalised terms used but not defined in the Terms have the meaning defined in the Twitter glossary.1
Interaction: Any interaction with @SanofiUK, i.e. retweet of a Tweet posted by @SanofiUK, Direct Message to@SanofiUK, Mention of @SanofiUK, Following of @SanofiUK, selection of any tweet posted by @SanofiUK as a Favourite done through Your Twitter account.
Interact: any Interaction activity.
Sanofi: The French company registered with the French Company Register under no B 395 030 844, having itsregistered office 54 rue La Boetie, 75008 Paris, France, and its Affiliates.
Sanofi-Aventis Groupe: The French company registered with the French Company Register under no B 403335 938, having its registered office 54 rue La Boetie, 75008 Paris, France.
Affiliates: Any company which controls, is controlled by or is under common control with Sanofi. For thepurposes hereof, control shall mean the direct or indirect ownership of at least fifty per cent (50%) of the voting share capital of any company or the power to designate a majority of the members of its principal management body.

2. Purpose of @SanofiUK

@SanofiUK is managed by Aventis Pharma Limited. @SanofiUK is the official Corporate Twitter account of Aventis Pharma Limited which is intended to share the latest news and updates from Sanofi in the UK. The content of this account is intended for a UK audience. It is not intended for medical advice or discussion about Sanofi drugs or other companies' drugs, or to report any side effects that may be associated with Sanofi products or products of other companies. Tweets from @SanofiUK may contain information or details regarding Sanofi activities that are not available or accessible in every country. If You have specific questions about Sanofi activities please contact Your local Sanofi office. These can be found at www.sanofi.co.uk.

3. Interactions with @SanofiUK

3.1. Regulation and law applicable to Sanofi.

As Aventis Pharma Limited operates in a regulated industry, the type of information which can be shared and discussed by and with @SanofiUK is limited. @SanofiUK is aimed at providing a forum for discussions regarding our partnership and commitment in improving the nation's health. @SanofiUK is not intended to discuss treatments or as a forum for reporting Sanofi's or other treatments' side effects, either actual or potential, associated with the use of drugs.

3.2. Language of Interaction
The language to communicate with @SanofiUK through Interaction is English.
In the event You communicate with @SanofiUK in another language than English, Sanofi cannot guarantee that You will receive an answer from Sanofi.

3.3. @replies and Direct Messages
@SanofiUK welcomes feedback and ideas from all users of Twitter and Followers, and endeavours to join the conversation wherever possible. However, Sanofi is not able to reply individually to all messages received via @SanofiUK.

3.4 Disclaimer
Sanofi is not responsible for Your Interactions and other third parties' Interactions. Sanofi does not approve or endorse the third parties' Interactions (e.g. Followers of @SanofiUK) or more generally any information posted by Twitter users even when they relate to its products or activities, does not warrant their accuracy, and assumes no responsibility or liability arising from content posted by third parties on Twitter nor for any error, omission, defamation, or libel, whether they constitute Interactions or not. Caution should be used before relying on any particular statements or opinions expressed in Interactions or about Sanofi's or Sanofi's products or activities.

Sanofi does not verify third parties' Interaction except as otherwise provided in article 5 below.

You may decide to follow @SanofiUK. Your following of @SanofiUK should not be mentioned or presented as an endorsement by Sanofi of Your activity on Twitter or anywhere else, including in Your Interactions. Unless otherwise expressly confirmed in writing, Sanofi are not responsible for Your activity on Twitter and in particular Your Interactions.

The Tweets tweeted via @SanofiUK shall not be considered as an invitation to invest. They shall not be interpreted as canvassing or public offering and do not constitute either an offer to subscribe, purchase or deal in Sanofi shares or any other securities issued by Sanofi and/or its Affiliates.

Sanofi reserves the right without prior notice and in its sole discretion to delete @SanofiUK or parts or all of its contents, at any time.

Twitter may occasionally be unavailable and Sanofi accepts no responsibility due to Twitter downtime. You acknowledge: (i) It is technically impossible that the @SanofiUK will be provided free of defaults and Sanofi cannot take any responsibility for this, (ii) that defaults may lead to the temporary unavailability of @SanofiUK, and that (iii) the operation of the account may be adversely affected by conditions and performances outside Sanofi's control, such as, for example, transmission and telecommunication links between Sanofi or You and Twitter and/or between Sanofi and other systems and networks. Sanofi, may at any time, temporarily or permanently, modify or interrupt all or part of @SanofiUK in order to make improvements and/or changes to the account. Sanofi is not liable for any modification to or suspension or interruption of the account.


3.5 Limitations of liability
Sanofi makes every effort to the best of its abilities to ensure the accuracy and updating of the information tweeted via @SanofiUK.
Sanofi cannot be held liable for:
any imprecision, inaccuracy or omission relative to the information provided via @SanofiUK;
any damage resulting from fraudulent intrusion by a third party leading to the modification of the information or materials provided via @SanofiUK;
In a more general way, any damage, direct or indirect, regardless of its cause, origin, nature or consequences, even whilst Sanofi has been aware of the possibility of such damage, whether it be the result of (i) access  or inability to access @SanofiUK, (ii) the use of Twitter or Interactions, including any damage or virus which  may infect Your computer system or any other product, and/or (iii) credit given to any information provided directly or indirectly by @SanofiUK.
The materials on @SanofiUK are provided "as is", without any kind of warranty, whether expressed or implied. Sanofi does not offer any expressed or implied warranty relative without limitation to their merchantability and fitness for a particular purpose.

4. No endorsement of third parties' activities

Sanofi does not endorse any third parties' activities on Twitter, whether through Interaction or not, unless otherwise expressly confirmed in writing.

In particular, @SanofiUK may decide to follow other Twitter accounts and select tweets posted by third parties as Favourites. Such Followings and Favourites shall in no case be considered as an endorsement of the followed Twitter accounts or of their activities. Sanofi shall in no case be held responsible of the activity of the Twitter accounts it follows or from which it selects tweets as Favourites through @SanofiUK.

Tweets from @SanofiUK may contain links to websites and other content that is not owned or controlled by Sanofi. Sanofi has no way of controlling the content of these third-party sites which remain totally independent of Sanofi.

In addition, the posting of a link by @SanofiUK toward a third-party's website or content shall in no case be considered as an endorsement of such content or website and Sanofi shall in no case be held responsible of any use to which such content or website may be put.

5. Monitoring and moderation

@SanofiUK will be updated and monitored during UK working days.

Sanofi will moderate all Mentions of @SanofiUK on Twitter and reserves the right to take appropriate actions in case of infringement of the Terms, including blocking the concerned Twitter account from Interaction and requesting Twitter to block the user concerned.

If Your Interaction or more generally any of Your posts on Twitter include possible adverse events or side effects associated with any Sanofi's product or treatment, Aventis Pharma Limited may be required to contact You for further information, in order to document the Adverse Event report, if required, to comply with safety regulatory obligations.

6. Governing law and disputes

You agree that the Terms shall be governed, construed and enforced in accordance with UK laws, without regard to principles of conflict of laws.

Any claim or dispute arising between You and Sanofi in connection with the validity, interpretation and performance in whole or in part from the Terms shall be decided exclusively by a court of competent jurisdiction located in the UK.

7. Miscellaneous

Please note, we cannot provide medical advice on your symptoms, if you are concerned about your symptoms, or they worsen, you should contact your doctor or healthcare provider.

Please check often for updates as Sanofi reserves the right, in its sole discretion, to modify these Terms at any time.

Updated: July 19, 2017

This site uses cookies to store information on your computer. Some cookies on this site are essential and the site won’t work as expected without them. To learn more about cookies and their benefits, please view our Cookie Policy.
By closing this message and/or continuing to use the website, you consent to our use of cookies on this device in accordance with our Cookie Policy unless you have disabled them.

Accept and close